Evidence map›Paper›PMID 36119044›Full record

ArticleFrontiers in immunology2022

Host inflammatory response is the major factor in the progression of

Zhenjie Zhang, Peihan Wang, Chuanmin Ma, Jing Wang, Wenxin Li, Chuansong Quan, Huae Cao, Hongfeng Guo, Liang Wang, Chengxin Yan and 3 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. ASM case reports · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Liver Function Abnormalities in Patients withInfection and drug resistance · 2025
    Article
  10. Clinical characteristics ofFrontiers in medicine · 2025
    Article
  11. Article
  12. Article
  13. Frontiers in medicine · 2024
    Article
  14. Case report: A clinical case study of six patients withFrontiers in cellular and infection microbiology · 2023
    Article
  15. Clinical features and risk factors of liver injury in patients withFrontiers in cellular and infection microbiology · 2023
    Article
  16. Infection and drug resistance · 2023
    Article
  17. Frontiers in medicine · 2023
    Article
  18. Clinical identification and microbiota analysis ofFrontiers in cellular and infection microbiology · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zhenjie ZhangKey Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Peihan WangBeijing Institute of Genomics, Chinese Academy of Sciences, China National Center for Bioinformation, Beijing, China.
Chuanmin MaKey Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Jing WangKey Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Wenxin LiDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Jining Medical University, Jining, China.
Chuansong QuanKey Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Huae CaoDepartment of Infectious Disease, Xintai Third People's Hospital, Xintai, China.
Hongfeng GuoDepartment of Infectious Disease, Xintai Third People's Hospital, Xintai, China.
Liang WangKey Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Chengxin YanDepartment of Medical Imaging, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
Michael J CarrNational Virus Reference Laboratory, School of Medicine, University College Dublin, Dublin, Ireland.
Ling MengDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
Weifeng ShiKey Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Methods: To clarify the host inflammatory response in psittacosis, we analyzed clinical parameters, and compared transcriptomic data, concentrations of plasma cytokines/chemokines, and changes of immune cell populations in 17 laboratory-confirmed psittacosis cases, namely, 8 pneumonia and 9 bronchitis individuals, in order to assess transcriptomic profiles and pro-inflammatory responses. Results: Psittacosis cases with pneumonia were found to have abnormal routine blood indices, liver damage, and unilateral pulmonary high-attenuation consolidation. Transcriptome sequencing revealed markedly elevated expression of several pro-inflammatory genes, especially interleukins and chemokines. A multiplex-biometric immunoassay showed that pneumonia cases had higher levels of serum cytokines (G-CSF, IL-2, IL-6, IL-10, IL-18, IP-10, MCP-3, and TNF-α) than bronchitis cases. Increases in activated neutrophils and decreases in the number of lymphocytes were also observed in pneumonia cases. Conclusion: We identified a number of plasma biomarkers distinct to

Indexed as

BronchitisChlamydophila psittaciPneumoniaPsittacosisBiomarkersChemokine CXCL10CytokinesGranulocyte Colony-Stimulating FactorHumansInterleukin-10Interleukin-18Interleukin-2Interleukin-6Transfer FactorTumor Necrosis Factor-alphaBiomarkersChemokine CXCL10CytokinesGranulocyte Colony-Stimulating FactorInterleukin-10Interleukin-18Interleukin-2Interleukin-6Transfer FactorTumor Necrosis Factor-alphaChlamydia psittacicommunity-acquired pneumoniainflammatory cytokinesinflammatory responsetranscriptomic profiling

Identifiers

PMID36119044
PMCPMC9478202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.